Emcure cuts Poviztra prices by up to 55% following Novo Nordisk’s move, lowering monthly treatment costs for semaglutide-based obesity therapy in India
Emcure cuts Poviztra prices by up to 55% following Novo Nordisk’s move, lowering monthly treatment costs for semaglutide-based obesity therapy in India by Soban News (international And National News)
